mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
2e-05 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-05 |